✦ LIBER ✦

Pharmacodynamic and clinical trials of glycoprotein IIb/IIIa inhibitors and potential relationship of results to dosing

✍ Scribed by Hobbach, Hans-Peter ;Schuster, Peter

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics and pharmacodynamics of

✍ Neal S. Kleiman 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 329 KB

An overview of the results of clinical t

✍ A.A.Jennifer Adgey 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 227 KB

Cost Efficacy of Platelet Glycoprotein I

✍ JOHN J. YOUNG; DEAN J. KEREIAKES 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 580 KB

Glycoprotein IIb-IIIa inhibition with ab

✍ Wojciech Mazur; Grzegorz L. Kaluza; Shelly Sapp; Craig Balog; Eric J. Topol; Dan 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 105 KB

Oral inhibitors of platelet membrane rec

✍ Pierre Théroux 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 105 KB

Clinical challenges of platelet glycopro

✍ James E Tcheng 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 111 KB